Referenser
- Fries J. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 18(Suppl 28)6–10
- Giercksky K E., Huseby G, Rugstad H E. Epidemiology of NSAID-related gastrointestinal side effects. Scand J Gastroenterol 1989; 24(163)3–8
- Türck D, Busch U, Heinzel G, Narjes H. Clinical pharmacokinetics of meloxicam. Eur J Rheumatol Inflanim 1995; 15: 23–30
- Verbeeck R K., Richardson C J., Blocka K LN. Clinical pharmacokinetics of piroxicam. J Rheumatol 1986; 13: 789–96
- Crevoisier C H., Heizmann P, Forgo I, Durbach U C. Plasma tenoxicam concentrations after single and multiple oral doses. Eur J Drug Metab Pharmacokin 1989; 14: 23–7
- Xie W, Robertson D L., Simmons D L. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 1992; 25(4)249–65
- Vane J. Towards a better aspirin. Nature 1994; 367: 215–6
- Engelhardt G. Meloxicam, a potent inhibitor of COX-2. Abstract presented at the 9th International Conference on Prostaglandins and Related Compounds, FlorenceItaly, June, 6–101994
- Churchill L, Graham A, Farina P, Grob P. Inhibition of human cyclooxygenase-2 (COX-2) by meloxicam. Rheumatol Eur 1995; 24(Suppl 3)272
- Pairet M, Engelhardt G, Lidbury P., Vane J R. Differential inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) by meloxicam and its 4 isomer, Submitted for publication
- Mitchell J A., Akarasereenont P, Thiemerman C HR, Flower R, Vane J R. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693–7
- Meade E A., Smith W L., De Witt D L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxyge-nase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610–4
- CSM update. Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions - 2. Br Med J 1986; 292: 1190–1
- Langman M J., Weil J, Wainwright P., et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–8
- Garcia Rodriguez L A., Jick H. Risks of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769–72